Sundt AS

Europe, Oslo, Norway, Oslo

Description

Privately owned investment company.

Investor Profile

Sundt AS has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

Concentrates on Series A, Series Unknown, Post Ipo Equity rounds (top funding stages).
Majority of deals are located in Norway, United States.
Strong thematic focus on Biotechnology, Analytics, Artificial Intelligence (AI).

Stage Focus

Series A (33%)
Series Unknown (33%)
Post Ipo Equity (33%)

Country Focus

Norway (67%)
United States (33%)

Industry Focus

Biotechnology
Analytics
Artificial Intelligence (Ai)
Big Data
Internet Of Things
Machine Learning
Software
Chemical
Life Science
Therapeutics

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sundt AS frequently co-invest with?

Geveran Trading

Europe, Limassol, Cyprus, Limassol

Co-Investments: 1

Canica

Europe, Oslo, Norway, Oslo

Co-Investments: 2

Europe, Oslo, Norway, Oslo

Co-Investments: 1

Europe, Oslo, Norway, Oslo

Co-Investments: 1

Horizon

Asia, Krung Thep, Thailand, Bangkok

Co-Investments: 1

Hadean Ventures

Hadean Ventures

Europe, Oslo, Norway, Oslo

Co-Investments: 1

Northgate Partners

North America, Connecticut, United States, Essex

Co-Investments: 1

Stokke Industri

Europe, Oslo, Norway, Oslo

Co-Investments: 1

Arctic Fund Management

Europe, Oslo, Norway, Oslo

Co-Investments: 1

StartX (Stanford-StartX Fund)

StartX (Stanford-StartX Fund)

North America, California, United States, Palo Alto

Co-Investments: 1

What are some of recent deals done by Sundt AS?

EXACT THERAPEUTICS AS

Oslo, Oslo, Norway

EXACT Therapeutics is a clinical stage biotech firm developing a technology platform for therapeutic enhancement Acoustic Cluster Therapy.

BiotechnologyTherapeutics

Post Ipo EquityDec 3, 2024

Amount Raised: $13,108,718

Oslo, Oslo, Norway

Oncoinvent develops new radiopharmaceutical products for better treatment options for cancer patients.

BiotechnologyChemicalLife Science

Series UnknownJun 29, 2021

Amount Raised: $29,204,004

Arundo Analytics

Palo Alto, California, United States

Arundo Analytics provides cloud-based and edge-enabled software for the deployment and management.

AnalyticsArtificial Intelligence (AI)Big DataInternet of ThingsMachine LearningSoftware

Series AJan 25, 2018

Amount Raised: $25,000,000

Find More Investors Like Sundt AS

Discover similar investors in our database and build your perfect investor list.

series_a Investors Investors in Oslo Browse All Investors Top Investors

Need help with your fundraising strategy?Read our fundraising guides